SEC Form 4 · accession 0000899243-19-003822
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanofi
10% Owner
Period of report
Feb 13, 2019
Accepted (ET)
Feb 15, 2019 · 6:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock (par value $0.0001) | Feb 13, 2019 | S | 4,168,899 | $37.66 | D | 0 | I | Via wholly-owned subsidiary, Aventis Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On February 13, 2019, the reporting person sold 4,168,899 shares of MYOK at a price of $37.66 (the "Transaction"). As a result of the Transaction, the reporting person no longer owns shares of common stock of MYOK and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of MYOK.